<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> are associated with <z:e sem="disease" ids="C0015930" disease_type="Disease or Syndrome" abbrv="">fetal distress</z:e> and fetal <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Although different therapeutic regimens have been used, the incidence of fetal <z:hpo ids='HP_0001510'>growth retardation</z:hpo> varies between 30 and 60 per cent of reported cases </plain></SENT>
<SENT sid="2" pm="."><plain>We report the evolution of fetal growth in patients with <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome treated with high-dose intravenous immunoglobulins (IVIG) </plain></SENT>
<SENT sid="3" pm="."><plain>Fourteen patients with a history of recurrent <z:hpo ids='HP_0005268'>spontaneous abortion</z:hpo> and immunological diagnosis of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> were followed longitudinally </plain></SENT>
<SENT sid="4" pm="."><plain>Intravenous immunoglobulin at a dose of 0.5 g/kg body weight for two consecutive days was started from the fifth week of pregnancy and repeated every 4 weeks until the 33rd week of gestation </plain></SENT>
<SENT sid="5" pm="."><plain>Fetal biometry was evaluated longitudinally from the appearance of the gestational sac at 4 weekly intervals </plain></SENT>
<SENT sid="6" pm="."><plain>In the period between 26 and 34 weeks, the frequency of evaluation was increased to every 14 days </plain></SENT>
<SENT sid="7" pm="."><plain>Data obtained were compared with a control group of 70 fetuses with uneventful pregnancies matched for gestational age </plain></SENT>
<SENT sid="8" pm="."><plain>Neonatal weight is shown in relation to the centiles for the <z:mpath ids='MPATH_458'>normal</z:mpath> population </plain></SENT>
<SENT sid="9" pm="."><plain>One patient out of 14 (7.1 per cent) developed gestational <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:hpo ids='HP_0011419'>abruptio placentae</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>No other <z:e sem="disease" ids="C0032962" disease_type="Disease or Syndrome" abbrv="">pregnancy complications</z:e> were seen </plain></SENT>
<SENT sid="11" pm="."><plain>No <z:hpo ids='HP_0000093'>proteinuria</z:hpo> was found </plain></SENT>
<SENT sid="12" pm="."><plain>The mean maternal age was 31.2 +/- 3.8 years </plain></SENT>
<SENT sid="13" pm="."><plain>Median birth weight was 3433 g +/- 287 </plain></SENT>
<SENT sid="14" pm="."><plain>The median centile of the birth weight was 65.3 +/- 18.6 </plain></SENT>
<SENT sid="15" pm="."><plain>Mean gestational age at delivery was 1.3 weeks </plain></SENT>
<SENT sid="16" pm="."><plain>No fetal or neonatal <z:hpo ids='HP_0001510'>growth retardation</z:hpo> was seen.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>